
Insmed’s once-daily TPIP prodrug shows sustained lung vasodilation in PAH and PH-ILD, improving walk distance, PALM outcomes, and quality of life.
The American Journal of Managed Care
about 24 years ago
A Word From the New Editorsabout 24 years ago
The Costs of Medical Research: Still Not a Simple Story to Tell





